Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Researchers from the Division win Oxford Sparks competition to have an animation created about research into Alzheimer's disease.

Before Christmas 2017, Oxford Sparks ran a competition which offered research groups the chance to win an animation about their research. The competition was won by members of the Alzheimer’s Research UK Oxford Drug Discovery Institute – Dr Hazel Hall-Roberts, a neuroimmunology cell biologist, and Keely Jones, the research group administrator – who will receive a bespoke animation to illustrate and explain their research. Alzheimer’s Research UK Oxford Drug Discovery Institute is based within the Nuffield Department of Clinical Medicine. 

The animation will explain the complex elements of Alzheimer's research, and highlight the importance of developing new drugs to treat the disease. The researchers will collaborate with professional animators to produce this short video about their research, and receive a dedicated social media campaign to publicise it. 

The other winner of the competition was Brooke Johnson, who is based in the Department of Earth Sciences in MPLS. 

Oxford Sparks is a public-facing online project that aims to bring alive the University's science research for wider audiences. Through a diverse range of digital content and activities they showcase and explain research, and encourage the public to engage with scientific research. They have already developed several animations with Medical Sciences researchers, and you can see some examples on their website

Find out more (MPLS news item)

 

 

Similar stories

Increased risk of some neurological and psychiatric disorders remains two years after COVID-19 infection

New diagnoses of disorders including psychosis, dementia, seizures and ‘brain fog’ remain commoner two years after COVID-19 than after other respiratory infections, whereas the increased risks of depression and anxiety after COVID-19 are short-lived and there is no overall excess of cases.

Sensory Supermarket event helps businesses make public-facing spaces more inclusive for autistic people

Researchers from the Universities of Oxford and Reading – in collaboration with awareness-raising organisation Sensory Spectacle – are hosting an innovative event called Sensory Supermarket as part of the Sensory Street research project.

Genetic mapping of tumours reveals how cancers grow

Researchers from the University of Oxford, KTH Royal Institute of Technology, Science for Life Laboratory, and the Karolinska Institutet, Solna, Sweden, have found that individual prostate tumours contain a previously unknown range of genetic variation.

Tackling suicide risk in people with mental disorders

Clinical researchers from Oxford University’s Department of Psychiatry and Oxford Health NHS Foundation Trust, together with colleagues from elsewhere, have developed guidance to help clinicians identify and treat patients at risk of suicide.

Environmental impact of 57,000 multi-ingredient processed foods revealed

A study estimating the environmental impact of 57,000 food products in the UK and Ireland has been published by an Oxford-led research team in the journal PNAS.

Oxford spinout MiroBio acquired by Gilead Sciences for $405m

The inflammatory diseases company’s rapid ascent and exit underscores the importance of friendships, partnerships and networks in innovation.